Impact of mirikizumab treatment on psoriasis disease activity at week 16 in patients based upon prior treatment with biologic therapy

The objective of this study is to determine treatment response at Week 16 in patients with psoriasis who previously received biologic therapy (Prior) and those who are naive to biologic therapy (Naive).
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research